OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients

J Nephrol. 2011 Sep-Oct;24(5):581-8. doi: 10.5301/JN.2011.6442.

Abstract

Introduction: The aim of this study was to assess the correlation between oxidized phospholipids on apolipoprotein B-100 particles (OxPL/ApoB), lipoprotein(a) and low-density lipoprotein (LDL)-producing oxidized phospholipid (OxLDL) biomarkers and cardiovascular disease (CVD) in chronic hemodialysis (HD) patients.

Methods: In 52 HD patients, we measured OxPL/apoB by antibody E06, IgG/IgM autoantibody titers to copper-oxidized LDL (Cu-OxLDL) and malondialdehyde (MDA)-LDL, IgG/IgM apolipoprotein B-100-immune complexes (IC/apoB), C-reactive protein (CRP) and lipoprotein(a) (Lp(a)). In all patients, the presence of CVD was assessed.

Results: OxPL/ApoB, IC IgG/IgM, MDA-LDL Ig G/IgM, Cu-OxLDL IgG/IgM and Lp(a) levels were similar in patients with and without CVD. At multiple logistic regression analysis, the association between age and CVD was independent (OR=1.078; 95% confidence interval, 1.005-1.157; p=0.03).

Conclusion: In HD patients, OxPL/apoB, lipoprotein(a) and OxLDL biomarkers are not associated with CVD.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antigen-Antibody Complex / blood
  • Apolipoproteins B / blood*
  • Autoantibodies / blood
  • Biomarkers / blood
  • C-Reactive Protein / analysis
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / etiology*
  • Female
  • Humans
  • Italy
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / therapy*
  • Lipoprotein(a) / blood*
  • Lipoproteins, LDL / blood*
  • Logistic Models
  • Male
  • Malondialdehyde / blood
  • Middle Aged
  • Odds Ratio
  • Oxidation-Reduction
  • Oxidative Stress
  • Phospholipids / blood*
  • Renal Dialysis*
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors

Substances

  • Antigen-Antibody Complex
  • Apolipoproteins B
  • Autoantibodies
  • Biomarkers
  • Lipoprotein(a)
  • Lipoproteins, LDL
  • Phospholipids
  • oxidized low density lipoprotein
  • Malondialdehyde
  • C-Reactive Protein